CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus

Bibliographic Details
Main Authors:	B. Wigdahl, C.-H. Chung, A.G. Allen, A.J. Atkins, R. Costello, N.T. Sullivan, M.R. Nonnemacher, W.N. Dampier
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020302181

Similar Items

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01)

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015-12-01)

Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
by: Ravichantar, Nithya
Published: (2020)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017-12-01)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01)

Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy
by: Will Dampier, et al.
Published: (2024-01-01)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020-09-01)

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
by: M. Nonnemacher, et al.
Published: (2015-12-01)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019-12-01)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01)

PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy
by: R. Berman, et al.
Published: (2022-12-01)

Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
by: Alexander G. Allen, et al.
Published: (2023-04-01)

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
by: Alex Olson, et al.
Published: (2020-10-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
by: Alexander G. Allen, et al.
Published: (2018-12-01)

Targeting and Understanding HIV Latency: The CRISPR System against the Provirus
by: Gloria Magro, et al.
Published: (2021-09-01)

Quantitative analysis of CRISPR/Cas9-mediated provirus deletion in blue egg layer chicken PGCs by digital PCR
by: Stefanie Altgilbers, et al.
Published: (2022-09-01)

Insertion of sequences at the original provirus integration site of mouseROSA26 locus using the CRISPR/Cas9 system
by: Rolen M. Quadros, et al.
Published: (2015-01-01)

Mild cognitive impairment in a clinically latent HIV-1 patient population
by: K.N. Devlin, et al.
Published: (2015-12-01)

Chromatin control of Tat-mediated reactivation of latent HIV-1 provirus
by: Ségéral Emmanuel, et al.
Published: (2009-09-01)

A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes
by: Zaohua Huang, et al.
Published: (2017-07-01)

Insertion sequence transposition inactivates CRISPR-Cas immunity
by: Yong Sheng, et al.
Published: (2023-07-01)

Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins
by: Yuwei Zhu, et al.
Published: (2018-03-01)

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
by: Satinder Dahiya, et al.
Published: (2014-01-01)

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy
by: Hager Mohamed, et al.
Published: (2023-01-01)

7 A single-cell method to detect early activation of the latent HIV provirus
by: J.P. Svensson
Published: (2017-07-01)

HIV- Bidirectional Encoder Representations From Transformers: A Set of Pretrained Transformers for Accelerating HIV Deep Learning Tasks
by: Will Dampier, et al.
Published: (2022-05-01)

Phages Fight Back: Inactivation of the CRISPR-Cas Bacterial Immune System by Anti-CRISPR Proteins.
by: Karen L Maxwell
Published: (2016-01-01)

Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes.
by: Renée M van der Sluis, et al.
Published: (2013-03-01)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015-12-01)

Gene inactivation by CRISPR-Cas9 in Nicotiana tabacum BY-2 suspension cells
by: Sébastien eMercx, et al.
Published: (2016-02-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
by: Ferdy R van Diemen, et al.
Published: (2016-06-01)

Applications of CRISPR/Cas to Improve Crop Disease Resistance: Beyond Inactivation of Susceptibility Factors
by: Dirk Schenke, et al.
Published: (2020-09-01)

Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
by: Xiao Wang, et al.
Published: (2021-09-01)

Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
by: Olaf Voets, et al.
Published: (2017-01-01)

The synergistic effect of PKA activator and HDAC inhibitor to reactivate HIV-1 provirus from latently infected cells
by: B.S. Choi, et al.
Published: (2015-12-01)

HIV-Quasipore: A Suite of HIV-1-Specific Nanopore Basecallers Designed to Enhance Viral Quasispecies Detection
by: Robert W. Link, et al.
Published: (2022-05-01)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

A quantitative single cell, single molecule RNA-FISH+IF and single cell RNA-seq analysis reveals stochasticity of reactivation of latent provirus
by: G. Kalpana, et al.
Published: (2019-12-01)